Abstract
Purpose. A Monte-Carlo computer simulation technique was employed to study the details of the small intestinal transit flow in the gastrointestinal (GI) tract.
Methods. A heterogeneous tube model was constructed using a numerical computer simulation technique. The model was built from first principles and included several heterogeneous characteristics of the GI tract structure. We used a random, dendritic-type internal structure representing the villi of the GI tract. The small intestinal transit flow was simulated using two diffusion models, namely, the blind ant and the myopic ant models, which are different models to account the elapse of time, and which are both based on statistical properties of random walks. For each one of the models we utilize two types of biased random walk, placing different emphasis in the motion towards the output of the tube. We monitored the flow of the drug in terms of Monte-Carlo time steps (MCS) through the tube walls and dendritic villi present.
Results. The frequency of the transit times was dependent on the structure of the dendritic villi and on the type of biased random walk. The small intestinal flow profile of literature data for a large number of drugs was well characterized by the heterogeneous model using, as parameters, a certain number of villi per unit length of the tube and specific characteristics for both types of the biased random walk. A correspondence between the MCS and real time units was achieved.
Conclusions. The transit process of the oral dosage forms in the GI tract can be reproduced with the heterogeneous model developed. This model can be used to study GI absorption phenomena.
Similar content being viewed by others
REFERENCES
J. B. Dressman, D. Fleisher, and G. L. Amidon. Physicochemical model for dose-dependent drug absorption. J. Pharm. Sci. 73:1274–1278 (1984).
J. B. Dressman and D. Fleisher. Mixing-tank model for predicting dissolution rate control of oral absorption. J. Pharm. Sci. 75:109–116 (1986).
R. J. Hintz and K. C. Johnson. The effect of particle size distribution on dissolution rate and oral absorption. Int. J. Pharm. 51: 9–17 (1989).
P. Luner and G. L. Amidon. Description and simulation of a multiple mixing-tank model to predict the effect of bile sequestrants on bile salt excretion. J. Pharm. Sci. 82:311–318 (1993).
R. L. Oberle and G. L. Amidon. The influence of variable gastric emptying and intestinal transit rates on the plasma level curve of cimetidine; An explanation for the double peak phenomenon. J. Pharmacok. Biopharm. 15:529–544 (1987).
L. X. Yu, J. R. Crison, and G. L. Amidon. Compartmental transit and dispersion model analysis of small intestinal transit flow in humans. Int. J. Pharm. 140:111–118 (1996).
D. M. Oh, R. L. Curl, and G. L. Amidon. Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in humans: a mathematical model. Pharm. Res. 10:264–270 (1993).
G. L. Amidon, H. Lennernas, V. P. Shah, and J. R. Crison. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res. 12:413–420 (1995).
N. F. H. Ho, H. P. Merkle, and W. I. Higuchi. Quantitative, mechanistic and physiologically realistic approach to the biopharmaceutical design of drug delivery systems. Drug Devel. Ind. Pharm. 9:1111–1184 (1983).
P. Macheras and P. Argyrakis. Gastrointestinal drug absorption: Is it time to consider heterogeneity as well as homogeneity? Pharm. Res. 14:842–847 (1997).
T. A. J. Witten and L. M. Sander. Diffusion-limited aggregation, a kinetic critical phenomenon. Phys. Rev. Lett. 47:1400–1403 (1981).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kalampokis, A., Argyrakis, P. & Macheras, P. Heterogeneous Tube Model for the Study of Small Intestinal Transit Flow. Pharm Res 16, 87–91 (1999). https://doi.org/10.1023/A:1018874913372
Issue Date:
DOI: https://doi.org/10.1023/A:1018874913372